This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:mp [08.21.2017] – [Olmesartan (Benicar)] sallieq | home:mp [09.20.2017] – [Safety considerations] " telmesartan sallieq | ||
---|---|---|---|
Line 60: | Line 60: | ||
* Patients on the MP should not take nimesulide (Aulin / Mesulid / Nimed). | * Patients on the MP should not take nimesulide (Aulin / Mesulid / Nimed). | ||
* Rivaroxaban (Xarelto) increases the risk of bleeding and can cause serious or fatal bleeding. A specific antidote for rivaroxaban is not available. | * Rivaroxaban (Xarelto) increases the risk of bleeding and can cause serious or fatal bleeding. A specific antidote for rivaroxaban is not available. | ||
+ | * Do not give Telmisartan, | ||
* Azithromycin is no longer regarded as safe, even in the small quantities formerly recommended for optional use while on MP | * Azithromycin is no longer regarded as safe, even in the small quantities formerly recommended for optional use while on MP | ||
* **For sicker patients, immunopathology can be physically and mentally challenging** – Support from a knowledgeable doctor and family/ | * **For sicker patients, immunopathology can be physically and mentally challenging** – Support from a knowledgeable doctor and family/ |